C. Ola Landgren/LinkedIn
May 19, 2025, 01:08
C. Ola Landgren: The 2nd Annual “Advancing Precision Medicine: Frontiers in MM Management” has been a huge success
C. Ola Landgren, Leader, Translational and Clinical Oncology Program/Experimental Therapeutics at Sylvester Comprehensive Cancer Center, shared the following insightful post on LinkedIn:
“WOW!! Full house! The 2nd Annual “Advancing Precision Medicine: Frontiers in Multiple Myeloma Management” in beautiful Miami has been a huge success today!
All the latest clinical and scientific myeloma data, new ideas on how to innovate the myeloma field, and how to develop a cure.
FACULTY:
Dr C. Ola Landgren, University of Miami, Miami
Dr Ben Derman, University of Chicago, Chicago
Dr Damian Green, University of Miami, Miami
Dr Ruben Niesvizky, Cornell University, New York
Dr Dickran Kazandjian, University of Miami, Miami
Dr Urvi Shah, Memorial Sloan Kettering Cancer Center, New York
Dr Ken Shain, Moffitt Cancer Center, TampaProgram organized by Sylvester Myeloma Institute at Sylvester Comprehensive Cancer Center, University of Miami and Plexus Communications
Thank you to all speakers for outstanding talks. Thank you to all sponsors who made the meeting possible. Thank you to all attendees for great questions and for interaction. Thank you to Plexus Communications for excellent meeting management. See you next year!”
More posts featuring C. Ola Landgren.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 29, 2025, 14:15
May 29, 2025, 13:35